Improvement of RBD-FC Immunogenicity by Using Alum-Sodium Alginate Adjuvant Against SARS-COV-2

被引:1
|
作者
Dehghan, Mahboobeh [1 ]
Askari, Hossein [1 ]
Tohidfar, Masoud [1 ]
Siadat, Seyed Omid Ranaei [2 ]
Fatemi, Fataneh [2 ]
机构
[1] Shahid Beheshti Univ, Fac Life Sci & Biotechnol, Dept Cellular & Mol Biol, Tehran, Iran
[2] Shahid Beheshti Univ, Prot Res Ctr, Tehran, Iran
关键词
aluminum hydroxide; cytokine; immunogenicity; RBD-FC; SARS-CoV-2; sodium alginate; vaccine; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; VACCINE ADJUVANTS; DELIVERY-SYSTEMS; CHITOSAN; CORONAVIRUSES; ANTIBODIES;
D O I
10.1111/irv.70018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundAdjuvants use several mechanisms to boost immunogenicity and to modulate immune response. The strength of adsorption of antigen by adjuvants can be a determinant factor for significant improvement of immunopotentiation.MethodsWe expressed recombinant RBD-FC in PichiaPink Strain 4 and examined the vaccination of mice by vaccine formulation with different adjuvants (sodium alginate and aluminum hydroxide, alone and together).ResultsSodium alginate significantly increased the immunogenicity and stability of RBD-FC antigen, so RBD-FC formulated with combined alginate and alum (AlSa) and sodium alginate alone showed higher antibody titer and stability. Immunogenicity of RBD-FC:AlSa was determined by serological assays including direct enzyme-linked immunosorbent assay (ELISA) and surrogate virus neutralization test (sVNT). High levels of IgGs and neutralizing antibodies were measured in serum of mice immunized with the RBD-FC:AlSa formulation. On the other hand, cytokines IL-10 and INF-gamma were severely accumulated in response to RBD-FC:AlSa, and after 10 days, their accumulation was significantly declined, whereas IL-4 showed the highest and the lowest accumulation in response to alum and alginate, respectively.ConclusionsOur data may suggest that combination of alum and sodium alginate has a better compatibility with RBD-FC in vaccine formulation.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
    Rutten, Lucy
    Swart, Maarten
    Koornneef, Annemart
    Bouchier, Pascale
    Blokland, Sven
    Sadi, Ava
    Juraszek, Jarek
    Vijayan, Aneesh
    Schmit-Tillemans, Sonja
    Verspuij, Johan
    Choi, Ying
    Daal, Chenandly E.
    Perkasa, Aditya
    Torres Morales, Shessy
    Myeni, Sebenzile K.
    Kikkert, Marjolein
    Tolboom, Jeroen
    van Manen, Danielle
    Kuipers, Harmjan
    Schuitemaker, Hanneke
    Zahn, Roland
    Langedijk, Johannes P. M.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [22] Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
    Phoolcharoen, Waranyoo
    Shanmugaraj, Balamurugan
    Khorattanakulchai, Narach
    Sunyakumthorn, Piyanate
    Pichyangkul, Sathit
    Taepavarapruk, Pornnarin
    Praserthsee, Wanlapa
    Malaivijitnond, Suchinda
    Manopwisedjaroen, Suwimon
    Thitithanyanont, Arunee
    Srisutthisamphan, Kanjana
    Jongkaewwattana, Anan
    Tomai, Mark
    Fox, Christopher B.
    Taychakhoonavudh, Suthira
    VACCINE, 2023, 41 (17) : 2781 - 2792
  • [23] Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC-MS to confirm strain selection and detect contaminations from other strains
    Suwanchaikasem, Pipob
    Rattanapisit, Kaewta
    Strasser, Richard
    Phoolcharoen, Waranyoo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models
    Choque-Guevara, Ricardo
    Poma-Acevedo, Astrid
    Montesinos-Millan, Ricardo
    Rios-Matos, Dora
    Gutierrez-Manchay, Kristel
    Montalvan-Avalos, Angela
    Quinones-Garcia, Stefany
    De Grecia Cauti-Mendoza, Maria
    Agurto-Arteaga, Andres
    Ramirez-Ortiz, Ingrid
    Criollo-Orozco, Manuel
    Huaccachi-Gonzales, Edison
    Romero, Yomara K.
    Perez-Martinez, Norma
    Isasi-Rivas, Gisela
    Sernaque-Aguilar, Yacory
    Villanueva-Perez, Doris
    Ygnacio, Freddy
    Vallejos-Sanchez, Katherine
    Fernandez-Sanchez, Manolo
    Guevara-Sarmiento, Luis A.
    Fernandez-Diaz, Manolo
    Zimic, Mirko
    PLOS ONE, 2022, 17 (08):
  • [25] Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses
    Haghighi, Melika
    Khorasani, Akbar
    Karimi, Pegah
    Mahdavi, Mehdi
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 25 (05) : 554 - 561
  • [26] Evaluation of the broad-spectrum immunogenicity of RBD dimer mRNA vaccines against SARS-CoV-2 variants
    Zhao, Xu
    Wu, Xinkai
    Du, Pei
    Chen, Qian
    Ma, Xuehui
    Hu, Shixiong
    Wu, Chunli
    Yang, Huiting
    Ma, Renyi
    Li, Shuang
    Kong, Tianxiang
    Li, Ruiqi
    Feng, Yinghao
    Wang, Xiaoyun
    Rong, Xiaoyu
    Zheng, Anqi
    Lu, Jian
    Gao, George Fu
    Wang, Qihui
    Chinese Science Bulletin, 2024, 69 (33) : 4905 - 4916
  • [27] The Influence of Radioligand Therapy on Immunogenicity against SARS-CoV-2
    Kramer, Carsten
    Eismant, Aleksandr
    Mishra, Aditi
    Mueller, Corinna
    Landvogt, Christian
    Baum, Richard P.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [28] Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2
    Rodrigues, Kristen A.
    Rodriguez-Aponte, Sergio A.
    Dalvie, Neil C.
    Lee, Jeong Hyun
    Abraham, Wuhbet
    Carnathan, Diane G.
    Jimenez, Luis E.
    Ngo, Julia T.
    Chang, Jason Y. H.
    Zhang, Zeli
    Yu, Jingyou
    Chang, Aiquan
    Nakao, Catherine
    Goodwin, Benjamin
    Naranjo, Christopher A.
    Zhang, Libin
    Silva, Murillo
    Barouch, Dan H.
    Silvestri, Guido
    Crotty, Shane
    Love, J. Christopher
    Irvine, Darrell J.
    SCIENCE ADVANCES, 2021, 7 (50):
  • [29] Comment on the immunogenicity of the Noora vaccine against SARS-CoV-2
    Forthal, Donald N.
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (05)
  • [30] The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice
    Xu, Kangwei
    Li, Jing
    Lu, Xu
    Ge, Xiaoqin
    Wang, Kaiqin
    Wang, Jiahao
    Qiao, Zhizhong
    Quan, Yaru
    Li, Changgui
    VACCINES, 2024, 12 (01)